DePuy Synthes Spine expands indication for Synapse occipital-cervical-thoracic system

157

DePuy Synthes Spine, part of the DePuy Synthes Companies of Johnson & Johnson, has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its Synapse occipital-cervical-thoracic system with posterior cervical screws, the first time cervical screws have been indicated for use with a screw-rod posterior fixation system. Previously, screw placement in this system was limited to use for fixation in the thoracic spine (T1–T3) and occiput only.

“This is very exciting news as it will allow us in the surgeon community to further drive education and research on these important techniques. Additionally it enables us to work with companies like DePuy Synthes to create new, innovative solutions to help improve patient care in the posterior cervical space,” said Todd J Albert, surgeon in chief and medical director Korein-Wilson professor of orthopaedic surgery, Hospital for Special Surgery, Weill Cornell Medical College, New York, USA.

According to the American Academy of Orthopaedic Surgeons, the use of internal cervical fixation dates back more than 75 years and has evolved to include placing screws into the lateral masses of the cervical spine. However, until now, this technique has not been among the indications in product labelling.

The system, including Synapse, OC Fusion and Axon, is intended to provide immobilisation and stabilisation of spinal segments as an adjunct to fusion for the following acute and chronic instabilities of the craniocervical junction, the cervical spine (C1–C7) and the thoracic spine (T1–T3); traumatic spinal fractures and/or traumatic dislocations; instability or deformity; failed previous fusions (eg. pseudoarthrosis); tumours involving the cervical/thoracic spine; and degenerative disease, including intractable radiculopathy and/or myelopathy, neck and/or arm pain of discogenic origin as confirmed by radiographic studies, and degenerative disease of the facets with instability.

The system is also intended to restore the integrity of the spinal column even in the absence of fusion for a limited time period in patients with advanced stage tumours involving the cervical spine in whom life expectancy is of insufficient duration to permit achievement of fusion.

In order to achieve additional levels of fixation, the Axon and synapses systems may be connected to the Synthes Universal Spinal System using parallel connectors and tapered rods. The Synapse system can also be linked to the titanium DePuy Expedium spine system using the 3.5mm/5.5mm and 4.0mm/5.5mm titanium tapered rods.